These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9028948)

  • 1. Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy.
    Le M; Okuyama T; Cai SR; Kennedy SC; Bowling WM; Flye MW; Ponder KP
    Blood; 1997 Feb; 89(4):1254-9. PubMed ID: 9028948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
    Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
    Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo.
    Kolodka TM; Finegold M; Kay MA; Woo SL
    Somat Cell Mol Genet; 1993 Sep; 19(5):491-7. PubMed ID: 7980740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.
    Cai SR; Kennedy SC; Bowling WM; Flye MW; Ponder KP
    J Clin Invest; 1998 Jun; 101(12):2831-41. PubMed ID: 9637717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo.
    Kay MA; Li Q; Liu TJ; Leland F; Toman C; Finegold M; Woo SL
    Hum Gene Ther; 1992 Dec; 3(6):641-7. PubMed ID: 1482704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.
    Kay MA; Baley P; Rothenberg S; Leland F; Fleming L; Ponder KP; Liu T; Finegold M; Darlington G; Pokorny W
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):89-93. PubMed ID: 1729724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.
    Rettinger SD; Kennedy SC; Wu X; Saylors RL; Hafenrichter DG; Flye MW; Ponder KP
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1460-4. PubMed ID: 8108431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes.
    Hafenrichter DG; Wu X; Rettinger SD; Kennedy SC; Flye MW; Ponder KP
    Blood; 1994 Nov; 84(10):3394-404. PubMed ID: 7949094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral vector sequences may interact with some internal promoters and influence expression.
    Wu X; Holschen J; Kennedy SC; Ponder KP
    Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
    Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
    Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes.
    Nguyen TH; Pagès JC; Farge D; Briand P; Weber A
    Hum Gene Ther; 1998 Nov; 9(17):2469-79. PubMed ID: 9853514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors.
    Duan YY; Wu J; Zhu JL; Liu SL; Ozaki I; Strayer DS; Zern MA
    Gastroenterology; 2004 Oct; 127(4):1222-32. PubMed ID: 15480999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-directed gene therapy: evaluation of liver specific promoter elements.
    Hafenrichter DG; Ponder KP; Rettinger SD; Kennedy SC; Wu X; Saylors RS; Flye MW
    J Surg Res; 1994 Jun; 56(6):510-7. PubMed ID: 8015304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral mediated transfer and expression of human alpha 1-antitrypsin in cultured cells.
    Ledley FD; Grenett HE; Bartos DP; Woo SL
    Gene; 1987; 61(1):113-8. PubMed ID: 3502102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.
    Jaffe HA; Danel C; Longenecker G; Metzger M; Setoguchi Y; Rosenfeld MA; Gant TW; Thorgeirsson SS; Stratford-Perricaudet LD; Perricaudet M
    Nat Genet; 1992 Aug; 1(5):372-8. PubMed ID: 1302034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector.
    Kuriyama S; Yoshikawa M; Ishizaka S; Tsujii T; Ikenaka K; Kagawa T; Morita N; Mikoshiba K
    Cell Struct Funct; 1991 Dec; 16(6):503-10. PubMed ID: 1813147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a cDNA encoding murine coagulation factor X.
    Liang Z; Cooper A; DeFord ME; Carmeliet P; Collen D; Castellino FJ; Rosen ED
    Thromb Haemost; 1998 Jul; 80(1):87-91. PubMed ID: 9684791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors.
    Hung HL; Pollak ES; Kudaravalli RD; Arruda V; Chu K; High KA
    Blood; 2001 Feb; 97(4):946-51. PubMed ID: 11159521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice.
    Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y
    J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.